Evaluation of the effects of the Sodium-glucose cotransporter 2 inhibitors and sacubitril/valsartan combined therapy in patients with HFrEF: echocardiographic study.
11 May 2024 (08:00 - 20:00)
Organised by: 
About the speaker
IRCCS Foundation Agostino Gemelli University Hospital, Rome (Italy)
7 More presentations in this session
Miss H. Hauksdottir (Reykjavik, IS)
Doctor S. Zhou (Toronto, CA)
Doctor I. Isaia (Rochester, US)
Associate Professor M. Zdravkovic (Belgrade, RS)
Access the full session
The Event
Heart Failure 2024
11 May - 14 May 2024
